To access this material please log in or register

Register Authorize

The place of torasemide in current therapy for chronic heart failure

Belenkov Yu. N., Shakarjyants G. A.
State Budgetary Educational Institution of Higher Professional Education “I. M. Sechenov First Moscow State Medical University” of the RF Ministry of Health Care, Trubetskaya 8, Bldg. 2, Moscow 119991

Keywords: diuretics, torasemide, treatment, CHF

DOI: 10.18087/rhfj.2015.6.2158

Loop diuretics remain a basic component of drug therapy for CHF. Diuretics designed for the treatment of sodium and water retention in edema syndrome are the most potent and available drugs, which allow overcoming signs of hypervolemia in such patients. The major strategic objective of diuretic treatment is minimizing its potential adverse effect on mechanisms of CHF progression and sudden arrhythmic death with preservation of a stable and adequate diuretic response. This increases the need for new loop diuretics, such as torasemide.
  1. Беленков Ю. Н., Мареев В. Ю., Агеев Ф. Т. Хроническая сердечная недостаточность. Избранные лекции по кардиологии. – М.: «ГЭОТАР-Медиа», 2006. – 432с.
  2. Bratter DC. Diuretic therapy. N Engl J Med. 1998 Aug 6;339 (6):387–95.
  3. Bolke T, Achhammer I. Torasemide review of its pharmacology and therapeutic use. Drugs of Today. 1994;30 (8):1–28.
  4. Friedel HA, Buckley MM. Torasemide. A review of its pharmacological properties and therapeutic potential. Drugs. 1991 Jan;41 (1):81–103.
  5. Brunner G, von Bergmann K, Hacker W, von Mollendorff E. Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liver. Arzneimittelforschung. 1998 Jan;38 (1A): 176–9.
  6. Reyes AJ. Effects of diuretics on outputs and flows or urine and urinary solutes m healthy subjects. Drugs. 1991;41 (Suppl 3):35–59.
  7. Cosin J, Diez J. Torasemide in chronic heart failure results of the TORIC study. Eur J Heart Fail. 2002 Aug;4 (4):507–13.
  8. Yamato M, Sasaki T, Honda K, Fukuda M, Akutagawa O, Okamoto M, Hayashi T. Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure. Circ J. 2003 May;67 (5):384–90.
  9. Murray MD, Deer MM, Ferguson JA, Dexter PR, Bennett SJ, Perkins SM et al. Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med. 2001 Nov;111 (7):513–20.
  10. Spannheimer A, Muller K, Falkenstein P, Reitberger U, Gutzwiller F, Follath F. Long-term diuretic treatment in heart failure: are there differences between furosemide and torasemide? Praxis (Bern 1994). 2002 Sep 11;91 (37):1467–75.
  11. Muller K, Gamba G, Jaquet F, Hess B. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV – efficacy and quality of life. Eur J Heart Fail. 2003 Dec;5 (6):793–801.
  12. Uchida T, Yamanaga K, Nishikawa M, Ohtaki Y, Kido H, Watanabe M. Anti-aldosteronergic effect of torasemide. Eur J Pharmacol. 1991 Nov 26;205 (2):145–50.
  13. Uchida T, Yamanaga K, Kido H, Ohtaki Y, Watanabe M. Diuretic and vasodilating actions of torasemide. Cardiology. 1994;84 (Suppl 2):14–7.
  14. Karagueuzian HS. Targeting cardiac fibrosis: a new frontier in antiarrhythmic therapy? Am J Cardiovasc Dis. 2011;1 (2):101–9.
  15. Lopez B, Gonzalez A, Beaumont J, Querejeta R, Larman M, Diez J. Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure. J Am Coll Cardiol. 2007 Aug 28;50 (9):859–67.
  16. Isakova T, Anderson CA, Leonard MB, Xie D, Gutierrez OM, Rosen LK et al. Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort. Nephrol Dial Transplant. 2011 Apr;26 (4):1258–65.
  17. Lopez B, Querejeta R, Gonzalez A, Sanchez E, Larman M, Diez J. Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. J Am Coll Cardiol. 2004 Jun 2;43 (11):2028–35.
  18. Goodfriend TL, Ball DL, Oelkers W, Bahr V. Torasemide inhibits aldosterone secretion in vitro. Life Sci. 1998;63 (3):PL45–50.
  19. Tsutamoto T, Sakai H, Wada A, Ishikawa C, Ohno K, Fujii M et al. Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure. J Am Coll Cardiol. 2004 Dec 7;44 (11):2252–3.
  20. Агеев Ф. Т., Жубрина Е. С., Гиляревский С. Р., Мареев В. Ю., Хосева Е. Н., Голшмид М. В. и др. Сравнительная эффективность и безопасность длительного применения торасемида и фуросемида у больных с компенсированной сердечной недостаточностью. Влияние на маркеры фиброза миокарда. Журнал Сердечная Недостаточность. 2013;14 (2):55–62.
  21. Беркинбаев С. Ф., Джунусбекова Г. А, Исабекова А. Х. Клини­ческая эффективность петлевого диуретика торасемида в лечении больных хронической сердечной недостаточностью. Результаты Казахстанского многоцентрового исследования «ПОЭТ». Рациональная фармакотерапия в кардиологии. 2014;10 (5):495–9.
  22. Arumugam S, Sreedhar R, Miyashita S, Karuppagounder V, Thandavarayan RA, Giridharan VV et al. Comparative evaluation of torasemide and furosemide on rats with streptozotocin-induced diabetic nephropathy. Exp Mol Pathol. 2014 Aug;97 (1):137–43.
  23. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the diagnosis and treatment of acute and CHF of the European Society of Cardiology. Eur J Heart Fail. 2012 Aug;14 (8):803–69.
  24. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH et al. 2013 ACCF / AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Oct 15;62 (16):e147–239.
Belenkov Yu. N., Shakarjyants G. A. The place of torasemide in current therapy for chronic heart failure. Russian Heart Failure Journal. 2015;16 (6):391–395

To access this material please log in or register

Register Authorize
Ru En